Aldehyde oxidase: an enzyme of emerging importance in drug discovery.

J Med Chem

WorldWide Medicinal Chemistry, Pfizer Global Research and Development, Sandwich, Kent, CT13 9NJ, England.

Published: December 2010

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm100888dDOI Listing

Publication Analysis

Top Keywords

aldehyde oxidase
4
oxidase enzyme
4
enzyme emerging
4
emerging drug
4
drug discovery
4
aldehyde
1
enzyme
1
emerging
1
drug
1
discovery
1

Similar Publications

SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer's disease.

Mol Neurodegener

January 2025

Center for Cognition and Sociality, Life Science Institute (LSI), Institute for Basic Science (IBS), Daejeon, Republic of Korea.

Background: Alzheimer's Disease (AD) is a neurodegenerative disease with drastically altered astrocytic metabolism. Astrocytic GABA and HO are associated with memory impairment in AD and synthesized through the Monoamine Oxidase B (MAOB)-mediated multi-step degradation of putrescine. However, the enzymes downstream to MAOB in this pathway remain unidentified.

View Article and Find Full Text PDF

Theoretical Study of Antioxidant and Prooxidant Potency of Protocatechuic Aldehyde.

Int J Mol Sci

January 2025

Institute for Information Technologies Kragujevac, Department of Science, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia.

In this study, the antioxidant and prooxidant potency of protocatechuic aldehyde (PCA) was evaluated using density functional theory (DFT). The potency of direct scavenging of hydroperoxyl (HOO) and lipid peroxyl radicals (modeled by vinyl peroxyl, HC=CHOO) involved in lipid peroxidation was estimated. The repair of oxidative damage in biomolecules (lipids, proteins and nucleic acids) and the prooxidant ability of PCA phenoxyl radicals were considered.

View Article and Find Full Text PDF

The majority of naturally occurring mutations of the human gene , are associated with reduced or completely absent xanthine oxidoreductase (XOR) activity, leading to a disease known as classical xanthinuria, which is due to the accumulation and excretion of xanthine in urine. Three types of classical xanthinuria have been identified: type I, characterised by XOR deficiency, type II, caused by XOR and aldehyde oxidase (AO) deficiency, and type III due to XOR, AO, and sulphite oxidase (SO) deficiency. Type I and II are considered rare autosomal recessive disorders, a condition where two copies of the mutated gene must be present to develop the disease or trait.

View Article and Find Full Text PDF

Elucidating the Phase I metabolism of psilocin in vitro.

Arch Toxicol

January 2025

Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.

Psilocin is a well-studied controlled substance with potential psychotherapeutic applications. However, research gaps remain regarding its metabolism. Our objective was to elucidate a comprehensive Phase I metabolic profile of psilocin to support its forensic management and clinical development.

View Article and Find Full Text PDF

Petal senescence represents a crucial phase in the developmental continuum of flowers, ensuing tissue differentiation and petal maturation, yet anteceding seed formation and development. Instigation of petal senescence entails myriad of changes at the cytological, physiological and molecular dimensions, mirroring the quintessential characteristics of cell death. In the current investigation biochemical and molecular intricacies were scrutinized across various developmental stages (bud to the senescent phase).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!